Extracellular matrix and liver disease

Antioxidants and Redox Signaling

Volumn 21, Issue 7, 2014, Pages 1078-1097

  Arriazu, Elena ^a   De Galarreta, Marina Ruiz ^b   Cubero, Francisco Javier ^c   Varela Rey, Marta ^d   De Obanos, María Pilar Pérez ^e   Leung, Tung Ming ^f   Lopategi, Aritz ^g   Benedicto, Aitor ^a   Abraham Enachescu, Ioana ^a   Nieto, Natalia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Digna Biotech   (Spain)

^f SUNY Downstate Medical Center   (United States)

^g INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRILLAR COLLAGEN; METALLOPROTEINASE; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; APOPTOSIS; ENDOTHELIUM CELL; EPIGENETICS; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; HOMEOSTASIS; HUMAN; KUPFFER CELL; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SENESCENCE; STELLATE CELL; WOUND HEALING; ANIMAL; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER DISEASES; MYOFIBROBLASTS;

EID: 84900544298     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5697     Document Type: Review

References (162)

1. Ahmad W, Ijaz B, and Hassan S. Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med 10: 41, 2012.
2. Alford AI and Hankenson KD. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749-757, 2006.
3. Arriazu E, Perez de Obanos MP, Lopez-Zabalza MJ, Herraiz MT, and Iraburu MJ. Amino acid deprivation decreases intracellular levels of reactive oxygen species in hepatic stellate cells. Cell Physiol Biochem 26: 281-290, 2010.
4. Arriazu E, Ruiz de Galarreta M, Lopez-Zabalza MJ, Leung TM, Nieto N, and Iraburu MJ. GCN2 kinase is a key regulator of fibrogenesis and acute and chronic liver injury induced by carbon tetrachloride in mice. Lab Invest 93: 303-310, 2013.
5. Bataller R and Brenner DA. Liver fibrosis. J Clin Invest 115: 209-218, 2005.
6. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, and Housset C. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87: 292-303, 2007.
7. Bedossa P, Dargere D, and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38: 1449-1457, 2003.
8. Bird A. Perceptions of epigenetics. Nature 447: 396-398, 2007.
9. Bornstein P. Matricellular proteins: an overview. J Cell Commun Signal 3: 163-165, 2009.
10. Bosman FT and Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol 200: 423-428, 2003.
11. Brew K and Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803: 55-71, 2010.
12. Buck M and Chojkier M. A ribosomal S-6 kinasemediated signal to C/EBP-beta is critical for the development of liver fibrosis. PLoS One 2: e1372, 2007.
13. Byron A, Humphries JD, and Humphries MJ. Defining the extracellular matrix using proteomics. Int J Exp Pathol 2013 [Epub ahead of print]; DOI: 10.1111/iep.12011.
14. Castera L and Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59: 861-866, 2010.
15. Cederbaum AI. Hepatoprotective effects of S-adenosyl-Lmethionine against alcohol-and cytochrome P450 2E1-induced liver injury. World J Gastroenterol 16: 1366-1376, 2010.
16. Cederbaum AI. Alcohol metabolism. Clin Liver Dis 16: 667-685, 2012.
17. Chiquet-Ehrismann R and Tucker RP. Connective tissues: signalling by tenascins. Int J Biochem Cell Biol 36: 1085-1089, 2004.
18. Choi SS and Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology 50: 2007-2013, 2009.
19. Connolly MK, Bedrosian AS, Malhotra A, Henning JR, Ibrahim J, Vera V, Cieza-Rubio NE, Hassan BU, Pachter HL, Cohen S, Frey AB, and Miller G. In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity. J Immunol 185: 2200-2208, 2010.
20. Cox LA, Schlabritz-Loutsevitch N, Hubbard GB, Nijland MJ, McDonald TJ, and Nathanielsz PW. Gene expression profile differences in left and right liver lobes from midgestation fetal baboons: a cautionary tale. J Physiol 572: 59-66, 2006.
21. Cox TR and Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4: 165-178, 2011.
22. Cubero FJ and Nieto N. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor betadependent mechanisms. Hepatology 48: 2027-2039, 2008.
23. Cubero FJ and Nieto N. Arachidonic acid stimulates TNFalpha production in Kupffer cells via a reactive oxygen species-pERK1/2-Egr1-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 303: G228-G239, 2012.
24. Daley WP, Peters SB, and Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121: 255-264, 2008.
25. Diaz R, Kim JW, Hui JJ, Li Z, Swain GP, Fong KS, Csiszar K, Russo PA, Rand EB, Furth EE, and Wells RG. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39: 102-115, 2008.
26. Dong QY and Wu ZY. Advance in the pathogenesis and treatment of Wilson disease. Transl Neurodegener 1: 23, 2012.
27. Dooley S and ten Dijke P. TGF-beta in progression of liver disease. Cell Tissue Res 347: 245-256, 2012.
28. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 12: 22-37, 2008.
29. Fallowfield JA. Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 300: G709-G715, 2011.
30. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, and Iredale JP. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178: 5288-5295, 2007.
31. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440, 2007.
32. Ferguson-Smith AC and Greally JM. Epigenetics: perceptive enzymes. Nature 449: 148-149, 2007.
33. Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pruzanski M, Morelli A, and Pellicciari R. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther 314: 584-595, 2005.
34. Frantz C, Stewart KM, and Weaver VM. The extracellular matrix at a glance. J Cell Sci 123: 4195-4200, 2010.
35. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 38 Suppl 1: S38-S53, 2003.
36. Friedman SL. Reversibility of hepatic fibrosis and cirrhosis-is it all hype? Nat Clin Pract Gastroenterol Hepatol 4: 236-237, 2007.
37. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172, 2008.
38. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008.
39. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, and Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 41: 1074-1084, 2005.
40. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21: 311-335, 2001.
41. Gelse K, Poschl E, and Aigner T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 55: 1531-1546, 2003.
42. Germani G, Burroughs AK, and Dhillon AP. The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology 57: 773-784, 2010.
43. Glässner A, Eisenhardt M, Kramer B, Korner C, Coenen M, Sauerbruch T, Spengler U, and Nattermann J. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL-and NKG2D-dependent manner. Lab Invest 92: 967-977, 2012.
44. Gordon MK and Hahn RA. Collagens. Cell Tissue Res 339: 247-257, 2010.
45. Gressner AM and Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGFbeta as major players and therapeutic targets. J Cell Mol Med 10: 76-99, 2006.
46. Guicciardi ME and Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis 30: 402-410, 2010.
47. Hall A, Germani G, Isgro G, Burroughs AK, and Dhillon AP. Fibrosis distribution in explanted cirrhotic livers. Histopathology 60: 270-277, 2012.
48. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, and Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89: 4963-4971, 2004.
49. Harder J, Opitz OG, Brabender J, Olschewski M, Blum HE, Nomoto S, and Usadel H. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. Int J Cancer 122: 2800-2804, 2008.
50. Hayflick L and Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
51. Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ, and Friedman SL. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142: 938-946, 2012.
52. Hernandez-Gea V, Hilscher M, Rozenfeld R, Lim MP, Nieto N, Werner S, Devi LA, and Friedman SL. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J Hepatol 59: 98-104, 2013.
53. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 326: 1216-1219, 2009.
54. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Hashimoto K, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, and Hamamoto Y. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 22: 3007-3014, 2003.
55. Inagaki Y and Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56: 284-292, 2007.
56. Iraburu MJ, Dominguez-Rosales JA, Fontana L, Auster A, Garcia-Trevijano ER, Covarrubias-Pinedo A, Rivas-Estilla AM, Greenwel P, and Rojkind M. Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta-and C/EBPdelta-dependent mechanism. Hepatology 31: 1086-1093, 2000.
57. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548, 2007.
58. Irie M, Sohda T, Iwata K, Kunimoto H, Fukunaga A, Kuno S, Yotsumoto K, Sakurai K, Iwashita H, Hirano G, Ueda SI, Yokoyama K, Morihara D, Nishizawa S, Anan A, Takeyama Y, Sakamoto M, Shakado S, and Sakisaka S. Levels of the oxidative stress marker gamma-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease. J Int Med Res 40: 924-933, 2012.
59. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJ, Benyon RC, and Iredale JP. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix crosslinking. Gastroenterology 126: 1795-1808, 2004.
60. Iwaisako K, Brenner DA, and Kisseleva T. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27 Suppl 2: 65-68, 2012.
61. Jarvelainen H, Sainio A, Koulu M, Wight TN, and Penttinen R. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61: 198-223, 2009.
62. Jiang F, Parsons CJ, and Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 45: 401-409, 2006.
63. Jiang JX, Mikami K, Venugopal S, Li Y, and Torok NJ. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NFkappaB-dependent pathways. J Hepatol 51: 139-148, 2009.
64. Johnson SJ, Hines JE, and Burt AD. Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 166: 351-358, 1992.
65. Jones RS. Epigenetics: reversing the 'irreversible'. Nature 450: 357-359, 2007.
66. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, and Lotersztajn S. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128: 742-755, 2005.
67. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, and Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 25: 1028-1031, 1997.
68. Keaney JF, Jr., Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ, and Framingham S. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434-439, 2003.
69. Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, and Iredale JP. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast prolif-eration and apoptosis in recovery from rodent liver fibrosis. Hepatology 49: 901-910, 2009.
70. Kim KH, Chen CC, Monzon RI, and Lau LF. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33: 2078-2090, 2013.
71. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, Poupon R, and Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83: 163-173, 2003.
72. Kisseleva T and Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22 Suppl 1: S73-S78, 2007.
73. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, and Brenner DA. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45: 429-438, 2006.
74. Kita Y, Takamura T, Misu H, Ota T, Kurita S, Takeshita Y, Uno M, Matsuzawa-Nagata N, Kato K, Ando H, Fujimura A, Hayashi K, Kimura T, Ni Y, Otoda T, Miyamoto K, Zen Y, Nakanuma Y, and Kaneko S. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS One 7: e43056, 2012.
75. Knupp C and Squire JM. Molecular packing in networkforming collagens. Adv Protein Chem 70: 375-403, 2005.
76. Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, and Gao B. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56: 1150-1159, 2012.
77. Konno S, Kurokawa M, Uede T, Nishimura M, and Huang SK. Role of osteopontin, a multifunctional protein, in allergy and asthma. Clin Exp Allergy 41: 1360-1366, 2011.
78. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, and Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667, 2008.
79. Leclercq IA, Sempoux C, Starkel P, and Horsmans Y. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. Gut 55: 1020-1029, 2006.
80. Lee M and Kowdley KV. Alcohol's effect on other chronic liver diseases. Clin Liver Dis 16: 827-837, 2012.
81. Lee SH, Seo GS, Park YN, Yoo TM, and Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 68: 2367-2378, 2004.
82. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, Morel F, and Zarski JP. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99: 271-279, 2004.
83. Li C, Kong Y, Wang H, Wang S, Yu H, Liu X, Yang L, Jiang X, and Li L. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50: 1174-1183, 2009.
84. Lim MP, Devi LA, and Rozenfeld R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 2: e170, 2011.
85. Lorena D, Darby IA, Reinhardt DP, Sapin V, Rosenbaum J, and Desmouliere A. Fibrillin-1 expression in normal and fibrotic rat liver and in cultured hepatic fibroblastic cells: modulation by mechanical stress and role in cell adhesion. Lab Invest 84: 203-212, 2004.
86. Lu P, Takai K, Weaver VM, and Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3: pii:a005058, 2011.
87. Mandrekar P. Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 17: 2456-2464, 2011.
88. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, and Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138: 705-714, 714.e1-e4, 2010.
89. Mas VR, Fassnacht R, Archer KJ, and Maluf D. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 16: 287-297, 2010.
90. Matsuoka M and Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11: 599-605, 1990.
91. Midwood KS and Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3: 287-310, 2009.
92. Mitchell C, Couton D, Couty JP, Anson M, Crain AM, Bizet V, Renia L, Pol S, Mallet V, and Gilgenkrantz H. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol 174: 1766-1775, 2009.
93. Mormone E, Lu Y, Ge X, Fiel MI, and Nieto N. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology 142: 612-621 e5, 2012.
94. Munshi MK, Uddin MN, and Glaser SS. The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med (Maywood) 236: 557-566, 2011.
95. Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology 44: 1487-1501, 2006.
96. Nieto N. Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. Hepatology 45: 1433-1445, 2007.
97. Nieto N, Friedman SL, and Cederbaum AI. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J Biol Chem 277: 9853-9864, 2002.
98. Nieto N, Friedman SL, and Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35: 62-73, 2002.
99. Nieto N, Friedman SL, Greenwel P, and Cederbaum AI. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 30: 987-996, 1999.
100. Nieto N, Greenwel P, Friedman SL, Zhang F, Dannenberg AJ, and Cederbaum AI. Ethanol and arachidonic acid increase alpha 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. Role of H2O2 and cyclooxygenase-2. J Biol Chem 275: 20136-20145, 2000.
101. Novo E, di Bonzo LV, Cannito S, Colombatto S, and Parola M. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 41: 2089-2093, 2009.
102. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J, Vandongen HM, Syn WK, Baroni GS, Benedetti A, Schuppan D, and Diehl AM. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 118: 3331-3342, 2008.
103. Page-McCaw A, Ewald AJ, and Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233, 2007.
104. Pankov R and Yamada KM. Fibronectin at a glance. J Cell Sci 115: 3861-3863, 2002.
105. Pellicoro A, Ramachandran P, and Iredale JP. Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 5 Suppl 1: S26, 2012.
106. Perez de Obanos MP, Lopez-Zabalza MJ, Arriazu E, Modol T, Prieto J, Herraiz MT, and Iraburu MJ. Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells. Biochim Biophys Acta 1773: 1681-1688, 2007.
107. Perez de Obanos MP, Lopez Zabalza MJ, Prieto J, Herraiz MT, and Iraburu MJ. Leucine stimulates procollagen alpha1(I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation. J Cell Physiol 209: 580-586, 2006.
108. Perugorria MJ, Wilson CL, Zeybel M, Walsh M, Amin S, Robinson S, White SA, Burt AD, Oakley F, Tsukamoto H, Mann DA, and Mann J. Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology 56: 1129-1139, 2012.
109. Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, and Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem 51: 328-335, 2005.
110. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, and Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 34: 730-739, 2001.
111. Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, Moles A, Mann DA, Bobola N, Sharrocks AD, Thomson BJ, Zaitoun AM, Irving WL, Guha IN, Hanley NA, and Hanley KP. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 56: 1108-1116, 2012.
112. Qiang H, Lin Y, Zhang X, Zeng X, Shi J, Chen YX, Yang MF, Han ZG, and Xie WF. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int 26: 1126-1137, 2006.
113. Qin L and Han YP. Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis. Am J Pathol 177: 1915-1928, 2010.
114. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, and Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130: 435-452, 2006.
115. Rashid ST, Humphries JD, Byron A, Dhar A, Askari JA, Selley JN, Knight D, Goldin RD, Thursz M, and Humphries MJ. Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver. J Proteome Res 11: 4052-4064, 2012.
116. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, and Group LS. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128: 1898-1906, 2005.
117. Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol 3: a004978, 2011.
118. Ricard-Blum S and Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol (Paris) 53: 430-442, 2005.
119. Rogers S, Girolami M, Kolch W, Waters KM, Liu T, Thrall B, and Wiley HS. Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics 24: 2894-2900, 2008.
120. Rozario T and DeSimone DW. The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 341: 126-140, 2010.
121. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, and Forbes SJ. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130: 1807-1821, 2006.
122. Santos PC, Krieger JE, and Pereira AC. Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int J Mol Sci 13: 1497-1511, 2012.
123. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, and Nash CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362: 1675-1685, 2010.
124. Sasaki T, Fassler R, and Hohenester E. Laminin: the crux of basement membrane assembly. J Cell Biol 164: 959-963, 2004.
125. Saxena NK, Ikeda K, Rockey DC, Friedman SL, and Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762-771, 2002.
126. Saxena NK, Titus MA, Ding X, Floyd J, Srinivasan S, Sitaraman SV, and Anania FA. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 18: 1612-1614, 2004.
127. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, and Brenner DA. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34: 89-100, 2001.
128. Schwabe RF, Bataller R, and Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285: G949-G958, 2003.
129. Senoo H, Kojima N, and Sato M. Vitamin A-storing cells (stellate cells). Vitam Horm 75: 131-159, 2007.
130. Shimada H and Rajagopalan LE. Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells. Fibrogenesis Tissue Repair 5 Suppl 1: S12, 2012.
131. Skinner MK. Environmental epigenetic transgenerational inheritance and somatic epigenetic mitotic stability. Epigenetics 6: 838-842, 2011.
132. Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P, Chen Y, Moylan C, Jung Y, Bhattacharya SD, Teaberry V, Omenetti A, Abdelmalek MF, Guy CD, Adams DH, Kuo PC, Michelotti GA, Whitington PF, and Diehl AM. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53: 106-115, 2011.
133. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, and Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35: 49-61, 2002.
134. Takahara Y, Takahashi M, Wagatsuma H, Yokoya F, Zhang QW, Yamaguchi M, Aburatani H, and Kawada N. Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol 12: 6473-6499, 2006.
135. Tang M, Potter JJ, and Mezey E. Activation of the human alpha1(I) collagen promoter by leptin is not mediated by transforming growth factor beta responsive elements. Biochem Biophys Res Commun 312: 629-633, 2003.
136. Tarrats N, Moles A, Morales A, Garcia-Ruiz C, Fernandez-Checa JC, and Mari M. Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology 54: 319-327, 2011.
137. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, and Lotersztajn S. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12: 671-676, 2006.
138. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, and Martin GR. Laminin-a glycoprotein from basement membranes. J Biol Chem 254: 9933-9937, 1979.
139. Trebicka J, Hennenberg M, Odenthal M, Shir K, Klein S, Granzow M, Vogt A, Dienes HP, Lammert F, Reichen J, Heller J, and Sauerbruch T. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. J Hepatol 53: 702-712, 2010.
140. Tryndyak VP, Han T, Muskhelishvili L, Fuscoe JC, Ross SA, Beland FA, and Pogribny IP. Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyldeficient diet. Mol Nutr Food Res 55: 411-418, 2011.
141. Tsukamoto H. Redox regulation of cytokine expression in Kupffer cells. Antioxid Redox Signal 4: 741-748, 2002.
142. Tsukamoto H. Epigenetic mechanism of stellate cell transdifferentiation. J Hepatol 46: 352-353, 2007.
143. Um TH, Kim H, Oh BK, Kim MS, Kim KS, Jung G, and Park YN. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 54: 939-947, 2011.
144. Urtasun R, Cubero FJ, Vera M, and Nieto N. Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha. Gastroenterology 136: 1410-1422, e1-e4, 2009.
145. Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, and Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K/pAkt/NFkappaB signaling. Hepatology 55: 594-608, 2012.
146. Vakonakis I, Staunton D, Rooney LM, and Campbell ID. Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis. EMBO J 26: 2575-2583, 2007.
147. Varela-Rey M, Fontan-Gabas L, Blanco P, Lopez-Zabalza MJ, and Iraburu MJ. Glutathione depletion is involved in the inhibition of procollagen alpha1(I) mRNA levels caused by TNF-alpha on hepatic stellate cells. Cytokine 37: 212-217, 2007.
148. Varela-Rey M, Montiel-Duarte C, Oses-Prieto JA, Lopez-Zabalza MJ, Jaffrezou JP, Rojkind M, and Iraburu MJ. p38 MAPK mediates the regulation of alpha1(I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells(1). FEBS Lett 528: 133-138, 2002.
149. Veit G, Zimina EP, Franzke CW, Kutsch S, Siebolds U, Gordon MK, Bruckner-Tuderman L, and Koch M. Shedding of collagen XXIII is mediated by furin and depends on the plasma membrane microenvironment. J Biol Chem 282: 27424-27435, 2007.
150. Watson MR, Wallace K, Gieling RG, Manas DM, Jaffray E, Hay RT, Mann DA, and Oakley F. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol 48: 589-597, 2008.
151. Wells RG. Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12: 759-768, viii, 2008.
152. White ES, Baralle FE, and Muro AF. New insights into form and function of fibronectin splice variants. J Pathol 216: 1-14, 2008.
153. Wight TN and Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 301: G950-G955, 2011.
154. Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbe E, and Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 24: 100-111, 1996.
155. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, and Diehl AM. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50: 1421-1430, 2009.
156. Woodhoo A, Iruarrizaga-Lejarreta M, Beraza N, Garcia-Rodriguez JL, Embade N, Fernandez-Ramos D, Martinez-Lopez N, Gutierrez-De Juan V, Arteta B, Caballeria J, Lu SC, Mato JM, Varela-Rey M, and Martinez-Chantar ML. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology 56: 1870-1882, 2012.
157. Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J, and Fan D. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma. Dig Liver Dis 39: 167-172, 2007.
158. Yang MD, Chiang YM, Higashiyama R, Asahina K, Mann DA, Mann J, Wang CC, and Tsukamoto H. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 55: 1271-1281, 2012.
159. Yurchenco PD and Patton BL. Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharm Des 15: 1277-1294, 2009.
160. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, and Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347, 2007.
161. Zeybel M, Hardy T, Wong YK, Mathers JC, Fox CR, Gackowska A, Oakley F, Burt AD, Wilson CL, Anstee QM, Barter MJ, Masson S, Elsharkawy AM, Mann DA, and Mann J. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med 18: 1369-1377, 2012.
162. Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z, and Fan D. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract 62: 1056-1062, 2008. Kidney Diseases Kidney Diseases and Kidney Diseases